“…Of these papers, about half focused on human epidermal growth factor receptor 2 (HER2; Table ). − Biosensors were also developed for several other breast cancer biomarkers (or general cancer biomarkers assessed in breast cancer cells), which include miR-16 in MCF-7 cells (LOD, 16 fM), miR-21 (LOD, 0.1 fM), anterior gradient protein 2 homologue, extracellular vesicles, nucleolin (LODs, 6–8 cells/mL), ,,, CD44, platelet derived growth factor receptor beta, CA15-3 (LOD, 0.11 U/mL), and mucin 1 (LODs, 0.031 fM, 25 cells/mL, 0.25 pM, and 3.0 × 10 5 particles/μL). ,− …”